Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18389
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMavrouli, M. D.en
dc.contributor.authorSpanakis, N.en
dc.contributor.authorLevidiotou, S.en
dc.contributor.authorPoliti, C.en
dc.contributor.authorAlexiou, S.en
dc.contributor.authorTseliou, P.en
dc.contributor.authorHatzitaki, M.en
dc.contributor.authorFoundouli, K.en
dc.contributor.authorTsakris, A.en
dc.contributor.authorLegakis, N. J.en
dc.contributor.authorRoutsias, J. G.en
dc.date.accessioned2015-11-24T18:52:21Z-
dc.date.available2015-11-24T18:52:21Z-
dc.identifier.issn0882-8245-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18389-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAmino Acid Sequenceen
dc.subjectAntibodies, Viral/*blooden
dc.subjectCoxsackievirus Infections/*epidemiologyen
dc.subjectDiabetes Mellitus, Type 1/epidemiology/etiologyen
dc.subjectEnterovirus B, Human/*immunologyen
dc.subjectEnzyme-Linked Immunosorbent Assayen
dc.subjectGreece/epidemiologyen
dc.subjectHumansen
dc.subjectImmunoglobulin G/blooden
dc.subjectImmunoglobulin M/blooden
dc.subjectMolecular Sequence Dataen
dc.subjectSeroepidemiologic Studiesen
dc.titleSerologic prevalence of coxsackievirus group B in Greeceen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1089/vim.2006.0085-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17425417-
heal.identifier.secondaryhttp://online.liebertpub.com/doi/pdfplus/10.1089/vim.2006.0085-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractCoxsackieviruses are human enteroviruses, which have been associated with myocarditis/pericarditis and sudden death. In one investigation (Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, and Legakis NJ: J Clin Pathol 2005;58:357-360), a cluster of cases of fatal myocarditis in Greece was linked to coxsackievirus B3. The information from this investigation prompted us to study serologically the prevalence of coxsackieviruses B throughout Greece. Sera were obtained from 506 healthy blood donors from various transfusion centers, covering the entire country. All sera were tested for the presence of IgG and IgM antibodies, using ELISAs with various antigenic specificities: (1) heat-denatured coxsackievirus type B1 and B5 virions, (2) a synthetic peptide from the N terminus of the VP1 protein of coxsackievirus B3, and (3) a synthetic peptide from the N terminus of the VP1 protein of coxsackievirus B4. Sera positive for IgG antibodies against coxsackieviruses B1/B5, B3, and B4 were detected in 6.7 to 21.6% of the individuals tested in the various regions of Greece. Statistical analysis revealed that the highest prevalence of IgG antibodies against coxsackieviruses B1/B5 was found in blood donors from Crete (p = 0.025), whereas the highest prevalence against coxsackievirus B4 was detected in blood donors from Athens (p = 0.01). IgM antibodies against coxsackievirus B were detected at low percentage, less than 5%, with no significant viral preference for particular geographic regions. The preference of anti-coxsackievirus IgG antibodies for particular geographic regions could be potentially related to the previously reported clustering of cases of insulin-dependent diabetes mellitus and myocarditis in Athens and Crete, respectively.en
heal.journalNameViral Immunolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Mavrouli-2007-Serologic prevalence.pdf149.81 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons